Liver Diseases Therapeutics Market Is Growing at a CAGR of 8.6% from 2012 to 2018 : Transparency Market Research
Liver Diseases Therapeutics Market was worth USD 6.5 billion in 2011 and is expected to reach USD 10.9 billion in 2018, growing at a CAGR of 8.6% from 2012 to 2018. In the overall global market, anti-viral drugs are expected to create its lead position in terms of revenue generation by 2018. Anti-viral drugs will have a share of 32.7% of the global market followed by vaccines at 19.1% in 2018.
View full press release